STOCK TITAN

Blantyre Names New Director as It Holds 27.1M Shares (29%) of NCMI

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

Blantyre group disclosures show an aggregate 29.0% stake in National CineMedia, Inc. (NCMI), totaling 27,144,639 shares based on 93,710,120 outstanding shares as of July 31, 2025. The filing amends Item 4 to report a board change: Nathan "Tripp" Lane, previously designated under a Director Designation Agreement, has resigned and Blantyre has designated Simon Mullaly to replace him, expected to join the Board upon effectiveness of Lane's resignation. The Reporting Persons state they will continue to review their investment and may communicate with management, other shareholders or acquire or dispose of shares, and they reported no transactions in the past 60 days.

Positive

  • Material ownership: Reporting Persons beneficially own 27,144,639 shares, equal to 29.0% of outstanding common stock.
  • Board representation secured: Blantyre designated Simon Mullaly to replace Nathan Lane, confirming direct influence on governance.

Negative

  • Potential for future share transactions: Reporting Persons reserve the right to acquire or dispose of shares, introducing ownership and voting uncertainty.
  • Concentrated voting power: Shared voting/dispositive power over 29.0% of the class could pressure management or trigger contested actions.

Insights

TL;DR: Blantyre and affiliated entities hold a material 29.0% position in NCMI and have placed a new director, creating meaningful influence over strategy.

The aggregate 27,144,639-share holding represents a near-controlling minority stake at 29.0% of outstanding common stock, which can materially affect governance and strategic outcomes. The designation of Simon Mullaly to the Board under the existing Designation Agreement formalizes Blantyre's board influence. The statement that Reporting Persons may acquire or dispose of shares and will engage with management signals ongoing active monitoring and potential future portfolio moves that could affect liquidity and corporate decisions. No transactions were reported in the prior 60 days.

TL;DR: Board composition change confirms Blantyre's exercised governance rights; this is material to NCMI's board dynamics and oversight.

Blantyre's designation rights under the Director Designation Agreement led to the replacement of a director with Simon Mullaly, reinforcing the Reporting Persons' governance role. Holding 29.0% of the class and centralized shared voting/dispositive power implies significant collective influence over board decisions and shareholder matters. The filing's explicit reservation of rights to transact and to engage with management and other shareholders indicates continuing active involvement in governance and strategy execution.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D


Mubashir Mukadam
Signature:/s/ Mubashir Mukadam
Name/Title:Mubashir Mukadam
Date:09/29/2025
Blantyre Mulanje II GP Limited
Signature:/s/ Russell Burt
Name/Title:Russell Burt, Director
Date:09/29/2025
Blantyre Fund II (GP) Limited
Signature:/s/ Russell Burt
Name/Title:Russell Burt, Director
Date:09/29/2025
Blantyre Fund III (GP) Limited
Signature:/s/ Russell Burt
Name/Title:By: Russell Burt, Director
Date:09/29/2025
Blantyre Capital Limited
Signature:/s/ Mubashir Mukadam
Name/Title:Mubashir Mukadam, Director
Date:09/29/2025
Blantyre Mulanje II DAC
Signature:/s/ Mubashir Mukadam
Name/Title:By Blantyre Capital Limited, as Investment Advisor, By Mubashir Mukadam, Director
Date:09/29/2025
BSSF II Ireland DAC
Signature:/s/ Mubashir Mukadam
Name/Title:By Blantyre Capital Limited, as Investment Advisor, By Mubashir Mukadam, Director
Date:09/29/2025
BSSF III DAC
Signature:/s/ Mubashir Mukadam
Name/Title:By Blantyre Capital Limited, as Investment Advisor, By Mubashir Mukadam, Director
Date:09/29/2025
Blantyre Mulanje III GP Limited
Signature:/s/ Russell Burt
Name/Title:Russell Burt, Director
Date:09/29/2025
Blantyre Capital ICAV
Signature:/s/ Mubashir Mukadam
Name/Title:By Blantyre Capital Limited, as Investment Advisor, By Mubashir Mukadam, Director
Date:09/29/2025

FAQ

How many NCMI shares do the Reporting Persons beneficially own?

The Reporting Persons beneficially own 27,144,639 shares, representing 29.0% of NCMI's common stock based on 93,710,120 outstanding shares.

Who has been designated to the NCMI Board by Blantyre?

Blantyre has designated Simon Mullaly to replace Nathan "Tripp" Lane on the Board, effective upon Lane's resignation.

Did the Reporting Persons trade NCMI stock in the past 60 days?

No. The filing states none of the Reporting Persons engaged in transactions involving Common Stock during the past sixty days.

What rights do the Reporting Persons reserve regarding their NCMI investment?

They reserve the right to acquire or dispose of shares in open market or private transactions, including block sales or Rule 10b5-1 programs.

On what outstanding share count is the 29.0% calculated?

The percentage is calculated using 93,710,120 outstanding shares reported by the Issuer as of July 31, 2025.